image
Ocugen, Inc. OCGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.9386
-6.14 %
$ 270 M
Market Cap
-5.21
P/E
INCOME STATEMENT
6.04 M REVENUE
142.60%
Growth Rates
1Year 142.60%
3Years 421.25%
5Years 0.00%
7Years 0.00%
10Years 93.98%
-65.5 M OPERATING INCOME
22.78%
Growth Rates
1Year 22.78%
3Years -45.48%
5Years -16.83%
7Years -11.65%
10Years -14.55%
-63.1 M NET INCOME
22.46%
Growth Rates
1Year 22.46%
3Years -42.45%
5Years -48.81%
7Years -21.42%
10Years -9.39%
EFFICIENCY
Earnings Waterfall Ocugen, Inc.
image
Revenue 6.04 M
Cost Of Revenue 39.6 M
Gross Profit -33.5 M
Operating Expenses 71.6 M
Operating Income -65.5 M
Other Expenses -2.45 M
Net Income -63.1 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 6.0 2.5 0 42.6 K 0 0 0 0 0 0 8 K 26 K
GROSS PROFIT
Cost Of Revenue 39.6 1.1 0.6 6.35 K 60.6 K 49.6 K 1.5 1.7 1.6 0 0 0
Gross Profit (33.5) 1.4 (0.6) 36.3 K 60.6 K 49.6 K (1.5) (1.7) (1.6) 0 8 K 26 K
OPERATING INCOME
Operating Expenses 71.6 84.9 58.0 14.3 14.2 25.8 24.9 30.1 31.5 32.6 16.8 15.0
Selling, General and Administrative Expenses 32.0 35.1 22.9 8.0 6.1 10.2 9.4 8.5 8.3 6.7 4.8 3.1
Research and Development Expenses 39.6 49.8 35.1 6.4 8.1 15.6 15.6 21.6 23.2 25.9 11.9 11.9
Operating Income (65.5) (84.9) (58.0) (21.3) (14.2) (30.1) (24.9) (30.3) (31.8) (32.7) (16.8) (15.0)
PRE-TAX INCOME
Interest Income Expense 0 0 79 K 0.7 1.8 0.2 0.1 60 K (0.1) (0.2) 0 0.8
Total Other Income 2.5 2.3 (0.4) (0.5) (6.1) 11.9 (1.5) 14.1 (0.2) 9.9 (8.9) (2.0)
Pre-Tax Income (63.1) (81.4) (58.4) (21.8) (20.2) (8.6) (26.4) (16.2) (32.0) (22.8) (25.7) (16.9)
NET INCOME
Tax Provision 0 (4.0) 52 K 0.8 1.0 (15.8) (0.2) (15.8) (1.2) (10.5) 8.9 1.9
Net Income (63.1) (77.8) (58.4) (22.6) (21.2) (8.6) (26.4) (16.2) (32.0) (22.8) (25.7) (16.9)
EPS 0.26 0.36 0.3 0.2 1.53 14 69.9 68.2 145 891 121 79.7